Specialized preclinical research solutions to evaluate immune safety, function, and therapeutic efficacy.
Burleson Research Technologies (BRT) is a contract research organization specializing in immune safety, immunotoxicology, and preclinical efficacy research for pharmaceuticals, biologics, chemicals, and medical devices.
Our integrated in vivo, in vitro, ex vivo, and bioanalytical capabilities support customized research programs designed around each client’s scientific objectives.
Integrated in vivo, in vitro, ex vivo, and bioanalytical capabilities to evaluate immune safety, function, and therapeutic efficacy.
Rodent-based models to evaluate immune function, host resistance, and therapeutic efficacy.
Human cell-based and other in vitro assays to evaluate immune function and mechanistic responses.
Connecting mechanistic insight with functional outcomes through integrated in vitro, in vivo, ex vivo, and bioanalytical capabilities.
GLP-Compliant
AAALAC-Accredited Vivarium
OLAW Assurance
Providing specialized research solutions to clients around the globe since 1996.
Decades of specialized experience in immunotoxicology, immune safety, and preclinical research.
Whether you have a defined study plan or are still determining the right approach, our team can work with you to develop a customized research strategy aligned with your scientific objectives.
